191 related articles for article (PubMed ID: 10928378)
21. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
Mokhtar GM; Matter RM; Shawki H; Abdel Aziz MM
Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
[TBL] [Abstract][Full Text] [Related]
22. Blunted serum erythropoietin response to anemia in patients polytransfused for beta-thalassemia major.
Chen JS; Lin KH; Wang ST; Tsao CJ; Yeh TF
J Pediatr Hematol Oncol; 1998; 20(2):140-4. PubMed ID: 9544165
[TBL] [Abstract][Full Text] [Related]
23. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
[TBL] [Abstract][Full Text] [Related]
24. Serum erythropoietin levels in thalassemia intermedia.
Dore F; Bonfigli S; Gaviano E; Pardini S; Cianciulli P; Papa G; Longinotti M
Ann Hematol; 1993 Oct; 67(4):183-6. PubMed ID: 8218539
[TBL] [Abstract][Full Text] [Related]
25. [Hematologic findings and value of value of endogenous creatinine in patients following kidney transplantation].
Zadrazil J; Bachleda P; Krejcí K
Acta Univ Palacki Olomuc Fac Med; 1999; 142():103-6. PubMed ID: 10743736
[TBL] [Abstract][Full Text] [Related]
26. Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients.
Viprakasit V; Kankirawatana S; Akarasereenont P; Durongpisitkul K; Chotewuttakorn S; Tanphaichitr VS
Am J Hematol; 2002 Jul; 70(3):260-2. PubMed ID: 12118430
[TBL] [Abstract][Full Text] [Related]
27. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
[TBL] [Abstract][Full Text] [Related]
28. Automatic measurement of hemoglobin F in blood obtained from patients with hemoglobin E/E and beta-thalassemia/hemoglobin/E.
Tatsumi N; Tsuda I; Funahara Y; Bunyaratvej A; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():91-4. PubMed ID: 1284356
[TBL] [Abstract][Full Text] [Related]
29. Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
Lai ME; Vacquer S; Carta MP; Spiga A; Cocco P; Angius F; Mandas A; Dessì S
Blood Cells Mol Dis; 2011 Apr; 46(4):294-9. PubMed ID: 21402483
[TBL] [Abstract][Full Text] [Related]
30. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of serum erythropoietin detection in patients with cancer-related anemia].
Li LB; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):954-5. PubMed ID: 13129732
[TBL] [Abstract][Full Text] [Related]
32. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
[TBL] [Abstract][Full Text] [Related]
33. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
[TBL] [Abstract][Full Text] [Related]
34. [Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method--the clinical significance, Part 1: Relation to anemia in renal failure and hematological disorders].
Ohe Y; Akasaka K; Ohno Y; Kawagoe H; Kishimoto T; Sakai R; Tsujino T; Hara H; Fujita Y; Yoshida Y
Rinsho Byori; 1993 Mar; 41(3):249-54. PubMed ID: 8345655
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
[TBL] [Abstract][Full Text] [Related]
36. Protein C and protein S deficiency in thalassemic patients.
Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
[TBL] [Abstract][Full Text] [Related]
37. Erythropoiesis, erythropoietin and blood lead levels.
Liberatori R; Romeo R; Porcelli B; Barabesi L; Sartorelli P
G Ital Med Lav Ergon; 2011; 33(1):37-40. PubMed ID: 21417137
[TBL] [Abstract][Full Text] [Related]
38. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status.
Lombardi G; Matera R; Minervini MM; Cascavilla N; D'Arcangelo P; Carotenuto M; Di Giorgio G; Musto P
Haematologica; 1994; 79(5):406-12. PubMed ID: 7843626
[TBL] [Abstract][Full Text] [Related]
40. Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional a-globin and beta-globin gene.
Traeger-Synodinos J; Papassotiriou I; Vrettou C; Skarmoutsou C; Stamoulakatou A; Kanavakis E
Haematologica; 2001 Apr; 86(4):363-7. PubMed ID: 11325640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
